Vitrolife AB (publ)
SSE:VITR.ST
187.4 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Vitrolife AB (publ) |
Symbool | VITR.ST |
Munteenheid | SEK |
Prijs | 187.4 |
Beurswaarde | 25,372,916,557 |
Dividendpercentage | 0.55% |
52-weken bereik | 123.9 - 244.2 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Ms. Bronwyn Brophy |
Website | https://www.vitrolife.com |
An error occurred while fetching data.
Over Vitrolife AB (publ)
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes;
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)